Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin (DP3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01929798
Recruitment Status : Completed
First Posted : August 28, 2013
Last Update Posted : October 21, 2015
University of Virginia
Mayo Clinic
University of California, Santa Barbara
University of Padova
Information provided by (Responsible Party):
Sansum Diabetes Research Institute